From: Are doctors protected enough during COVID-19 in South Asia?
Study variables | India n = 25 (15%) | Pakistan n = 26 (15%) | Iran n = 87 (51%) | Bangladesh n = 19 (11%) | Afghanistan n = 13 (8%) | Total n = 170 (100%) |
---|---|---|---|---|---|---|
Gender | ||||||
Males | 22 (88%) | 22 (85%) | 81(93%) | 16(84%) | 4(31%) | 145(85%) |
Females | 0 (0%) | 4(15%) | 6(7%) | 2(11%) | 0(0%) | 12(7%) |
N/A | 3(12%) | 0(0%) | 0(0%) | 1(5%) | 9(69%) | 13(8%) |
Physician specialty | ||||||
Anesthesiologist | 0(0%) | 3(11.5%) | 5(6%) | 3(16%) | 0(0%) | 11(6.5%) |
Cardiologist | 0 (0%) | 1(4%) | 0(0%) | 0(0%) | 0(0%) | 1(0.5%) |
Pulmonary and critical care specialist | 1(4%) | 2(7.5%) | 5(6%) | 1(5%) | 0(0%) | 9(5.5%) |
Dermatologist | 0(0%) | 1(4%) | 1(1%) | 0(%) | 0(%) | 2(1%) |
Otolaryngologists | 0(0%) | 1(4%) | 2(2.5%) | 0(0%) | 0(0%) | 3(2%) |
General Physician | 11(44%) | 8(31%) | 34(39%) | 3(16%) | 2(15%) | 58(34%) |
Gynecologist/obstetrician | 0(0%) | 1(4%) | 2(2.5%) | 2(11%) | 0(0%) | 5(3%) |
Hematologist/oncologist | 0(0%) | 0(0%) | 2(2.5%) | 0(0%) | 0(0%) | 2(1%) |
Infectious disease specialist | 0(0%) | 0(0%) | 1(1%) | 0(0%) | 0(0%) | 1(0.5%) |
Medical intern | 0(0%) | 4(15%) | 0(0%) | 1(5%) | 0(0%) | 5(3%) |
Neurologist | 1(4%) | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 1(0.5%) |
Ophthalmologist | 0(0%) | 0(0%) | 2(2.5%) | 0(0%) | 0(0%) | 2(1%) |
Orthopedic surgeon | 3(12%) | 0(0%) | 1(1%) | 2(11%) | 0(0%) | 6(3.5%) |
Pediatrician | 0(0%) | 2(7.5%) | 8(9%) | 1(5%) | 1(8%) | 12(7%) |
Pathologist | 0(0%) | 2(7.5%) | 1(1%) | 1(5%) | 0(0%) | 4(2%) |
Psychiatrist | 0(0%) | 0(0%) | 3(3%) | 0(0%) | 0(0%) | 3(2%) |
Radiologist | 0(0%) | 0(0%) | 0(0%) | 1(5%) | 0(0%) | 1(0.5%) |
General surgeon | 0(0%) | 1(4%) | 7(8%) | 0(0%) | 1(8%) | 9(5.5%) |
N/A | 9(36%) | 0(0%) | 13(15%) | 4(21%) | 9(69%) | 35(21%) |
Type of practice | ||||||
Public | 3(12%) | 18(69%) | 4(5%) | 5(26%) | 3(23%) | 33(19%) |
Private | 18(72%) | 7(27%) | 14(16%) | 11(58%) | 1(8%) | 51(30%) |
N/A | 4(16%) | 1(4%) | 69(79%) | 3(16%) | 9(69%) | 86(51%) |
Mortality rate | ||||||
Per 1000 deaths | 2.5 | 9 | 10 | 16 | 27 | 7 |